Project ADHERE: Clinical Proof-of-Concept of a Tenofovir (TFV) Aptamer-Based Biosensor for Determining Adherence Using Different Dosing Regimens of Disoproxil Fumarate/Emtricitabine (TDF/FTC)
Latest Information Update: 05 Feb 2024
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Proof of concept; Therapeutic Use
- Acronyms ADHERE
- 12 Apr 2022 Status changed from active, no longer recruiting to completed.
- 29 Jul 2021 Status changed from recruiting to active, no longer recruiting.
- 05 May 2021 New trial record